We raise our price target to $305 (from $257) as we lift our 2026-2027 EPS estimates on strengthening Advanced Surface Technologies (AST) revenue and margin assumptions, driven by recovering semiconductor capital equipment spending.
Our raised price target also reflects increasing earnings multiples for our industrial technology peer group.
Revenue expanded more than 14% year over year to $295 million in 4Q:25, about 4% above our forecast, while margins continued to be affected by increased AST spending ahead of expected growth.
4Q:25 EPS of $1.99 increased from the year-earlier $1.57 on double-digit revenue growth in both segments and wider Sealing margins, and was ahead of our $1.94 forecast due to lower net interest expense than we modeled.
Management guided for 8%-12% revenue growth in 2026 underpinned by mid-single-digit organic Sealing expansion, bolstered by the 4Q:25 acquisitions of Overlook Industries and AlpHa Measurement Systems, and a high-single-digit increase for AST (second half loaded).
The company highlighted stronger AST equipment bookings in late 4Q:25 and early 2026.
Even after completing the Overlook and AlpHa acquisitions (for a combined $274 million), net leverage remained about 2.0x, near the midpoint of the target range, positioning the company for additional accretive M&A, in our view. We model cash conversion of almost 100% of adjusted EPS in 2026-2027.
Management noted the M&A pipeline remained robust with the company potentially targeting additional purchases in biopharma or compositional analysis.
Our raised $305 price target (from $257) is based on 29x (previously 27x) our raised 2028 EPS estimate of $10.51 (formerly our average 20272-2028 EPS forecast of $9.53). The higher multiple reflects rising peer group valuations. Our moderate risk rating is supported by strong cash conversion and the healthy balance sheet.
19 Feb 2026
Raise Price Target To $305 (From $257) And Lift 2026-2027 Estimates, Driven By Strong AST Segment Guidance; Growing Cash Flow Supports Continued Accretive M&A, In Our View
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Raise Price Target To $305 (From $257) And Lift 2026-2027 Estimates, Driven By Strong AST Segment Guidance; Growing Cash Flow Supports Continued Accretive M&A, In Our View
We raise our price target to $305 (from $257) as we lift our 2026-2027 EPS estimates on strengthening Advanced Surface Technologies (AST) revenue and margin assumptions, driven by recovering semiconductor capital equipment spending.
Our raised price target also reflects increasing earnings multiples for our industrial technology peer group.
Revenue expanded more than 14% year over year to $295 million in 4Q:25, about 4% above our forecast, while margins continued to be affected by increased AST spending ahead of expected growth.
4Q:25 EPS of $1.99 increased from the year-earlier $1.57 on double-digit revenue growth in both segments and wider Sealing margins, and was ahead of our $1.94 forecast due to lower net interest expense than we modeled.
Management guided for 8%-12% revenue growth in 2026 underpinned by mid-single-digit organic Sealing expansion, bolstered by the 4Q:25 acquisitions of Overlook Industries and AlpHa Measurement Systems, and a high-single-digit increase for AST (second half loaded).
The company highlighted stronger AST equipment bookings in late 4Q:25 and early 2026.
Even after completing the Overlook and AlpHa acquisitions (for a combined $274 million), net leverage remained about 2.0x, near the midpoint of the target range, positioning the company for additional accretive M&A, in our view. We model cash conversion of almost 100% of adjusted EPS in 2026-2027.
Management noted the M&A pipeline remained robust with the company potentially targeting additional purchases in biopharma or compositional analysis.
Our raised $305 price target (from $257) is based on 29x (previously 27x) our raised 2028 EPS estimate of $10.51 (formerly our average 20272-2028 EPS forecast of $9.53). The higher multiple reflects rising peer group valuations. Our moderate risk rating is supported by strong cash conversion and the healthy balance sheet.